Biological activity of tacrolimus (FK506) and its metabolites from whole blood of kidney transplant patients

被引：11

作者：

Alak, AM ^{[1
]}

Moy, S ^{[1
]}

机构：

[1] FUJISAWA USA INC,RES LAB,RUSH PRESBYTERIAN ST LUKES MED CTR,CHICAGO,IL

来源：

TRANSPLANTATION PROCEEDINGS | 1997年 / 29卷 / 05期

关键词：

D O I：

10.1016/S0041-1345(97)00460-0

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：2487 / 2490

页数：4

共 14 条

[1]

CHRISTIANS U, 1991, TRANSPLANT P, V23, P940

[2] VALIDATION AND QUALITY ASSURANCE PROGRAM FOR MONITORING TACROLIMUS (FK-506) CONCENTRATIONS IN PLASMA AND WHOLE-BLOOD [J].

DAMBROSIO, R ;

GIRZAITIS, N ;

JUSKO, WJ .

THERAPEUTIC DRUG MONITORING, 1993, 15 (05) :414-426

[3] MEASUREMENT OF BLOOD-CONCENTRATIONS OF FK506 (TACROLIMUS) AND ITS METABOLITES IN 7 LIVER GRAFT PATIENTS AFTER THE FIRST DOSE BY HPLC-MS AND MICROPARTICLE ENZYME-IMMUNOASSAY (MEIA) [J].

GONSCHIOR, AK ;

CHRISTIANS, U ;

BRAUN, F ;

WINKLER, M ;

LINCK, A ;

BAUMANN, J ;

SEWING, KF .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 38 (06) :567-571

[4]

GONSCHIOR AK, UNPUB

[5]

GOTO T, 1991, TRANSPL P, V23, P2713

[6]

GOTO T, 1987, TRANSPLANT P, V19, P4

[7]

GRANIER FC, 1991, TRANSPLANT P, V23, P2748

[8]

IWASAKI K, 1993, DRUG METAB DISPOS, V21, P971

[9]

IWASAKI K, 1995, DRUG METAB DISPOS, V23, P28

[10]

LHOEST G, 1995, J PHARMACOL EXP THER, V274, P622

← 1 2 →